<DOC>
	<DOCNO>NCT00154739</DOCNO>
	<brief_summary>The purpose study evaluate efficacy gemcitabine/cisplatin versus gemcitabine/epirubicin Stage IIIB/IV NSCLC term response rate overall survival .</brief_summary>
	<brief_title>Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin Non-Small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description>Most patient suffer nausea , vomit prolonged anorexia cisplatin treatment . Epirubicin anthracycline use widely treatment cancer . Our previous study epirubicin paclitaxel combination non-small cell lung cancer patient show response rate 52.6 % good median survival . However , patient suffer paclitaxel-related neurotoxicity . Chemotherapy may increase average 1 2 month median survival inoperable non-small cell lung cancer patient treat chemotherapy . However , chemotherapy may provide cure patient . Reduction side effect enhancement life quality patient important life prolongation patient . We design combination chemotherapy use gemcitabine epirubicin treatment inoperable non-small cell lung cancer . The treatment compare gemcitabine cisplatin combination .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<criteria>Histologic cytologic diagnosis stage IIIB/IV NSCLC No prior chemotherapy Age &gt; 18 year ECOG score &lt; 0 2 Bidimensionally measurable lesion WBC &gt; 4,000/ml , ANC &gt; 1,500/ml , platelet &gt; 100,000/ml Hb &gt; 10g/dl . ALT/AST &lt; 5 time x UNL , bilirubin &lt; 1.5times x UNL , creatinine &lt; 1.25 time x UNL , normal calcium level Life expectancy &gt; 12 week CNS metastasis , Concomitant myelosuppressive radiotherapy , C/T , hormonal therapy immunotherapy . Active congestive heart failure , angina and/or arrhythmia require therapy previous myocardial infarction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2005</verification_date>
	<keyword>Combination , Chemotherapy , non-small cell lung cancer</keyword>
</DOC>